Researched and authored by esteemed scientists Takeshi Kaneko, Akinobu Miyata, and Muneaki Takahata, the randomized, placebo-controlled, double-blind, comparative human study was designed to the same standards used in pharmaceutical drug trials. ...
Among these, Nirmatrelvir (PF-07321332) has emerged as a promising candidate, exhibiting potent antiviral activity by targeting the main protease of SARS-CoV-2, and has been marketed in combination with ritonavir as the first oral treatment for COVID-19 with the name of PaxlovidTM. T...
At the time of writing this review, 14 GMP Chinese medicine factories have obtained authorization for the manufacture of NRICM101; 12 products prepared by these GMP factories have been granted a special drug license for export and a temporary drug license (EUA) by Taiwan’s Ministry of Health ...
Jena, MD, PhD; Ateev Mehrotra, MD, MPH JAMA Internal Medicine Correction Additional Information About Source of Study Drug and Typographical Error in Supplement JAMA Internal Medicine Key Points Question Does adding ivermectin, an inexpensive and widely available antiparasitic drug, to the standard of...